Congressional Testimony of Presidential Advisers (CRS)
The suggestion that it would be inherently inappropriate for presidential advisers to testify under oath before Congress regarding the firing of U.S. attorneys was swiftly batted down with numerous references to a 2004 Congressional Research Service report (pdf) on the subject.
CRS analyst Harold C. Relyea identified dozens of cases in which presidential advisers had been summoned to testify to Congress, and did so. See “Presidential Advisers’ Testimony Before Congressional Committees: A Brief Overview,” April 14, 2004.
Without the permitting workforce needed for implementation, the American public will not reap the benefits of rural broadband access, resilient supply chains, and clean, accessible water.
Improving public awareness of FDA Advisory Committees would improve public trust and deter misinformation related to the approval of medical products.
FAS has been a leading voice for action on this topic, and has developed a compendium of 150+ heat-related federal policy recommendations.
Proposed bills advance research ecosystems, economic development, and education access and move now to the U.S. House of Representatives for a vote